September 2016 SPDS Book

SPDS Meeting, September 16-17, 2016 – Chair and Presenter Bios His most memorable analytical work, however, remains the suite of methods for monitoring glucosinolates and isothiocyanates in formulations involving Cruciferae , including assessment of their enzymatic conversion rate. Anton has been with USP for three-and-a-half years. He is responsible for the majority of botanical monographs in the USP-NF Dietary Supplements section. Anton dedicated a significant effort to development of the USP General Chapter <2251> Screening For Undeclared Drugs and Drug Analogues, and is currently compiling the USP Adulterants database. In line with the USP's “Up-To-Date" policy, he is continuously working to improve compendial analyses. Anton is interested in implementing advanced techniques for challenging analytes such as oligomeric proanthocyanidins and complex polysaccharides, as well as devising a practical route for adoption of chemometric procedures in pharmacopeial monographs. He is a member of AOAC (2004) and AOCS (2008).

SPENCER C ARTER, GENYSIS LABS

SPDS PROTEIN WORKING GROUP

Spencer Carter is Senior Vice President of Genysis Labs. Genysis Labs is a cGMP compliant, full service testing laboratory that has provided comprehensive analytical testing for the Dietary Supplement and Food & Beverage industries since 2008. Additionally, Genysis Labs specializes in developing patentable formulations in the field of sports nutrition. Backed by

an ISO 17025:2005 accreditation and a management team of highly qualified scientists, Genysis Labs is committed to providing accurate and timely testing services while maintaining a laboratory environment consistent with ISO/IEC 17025:2005 requirements. Spencer earned his Ph.D. in Analytical Chemistry from the University of Alberta, in Edmonton, Alberta, Canada. His thesis focused on the analysis of tamoxifen metabolites by non-aqueous capillary electrophoresis and mass spectrometry detection. Prior to Genysis Labs, he was Lab Director at Tandem Labs (now Covance). Tandem Labs is a contract research organization (CRO) in the pharmaceutical industry performing bioanalytical services. His work included method development, validation, and sample analysis of biological samples. He focused on high- throughput analysis and improving efficiencies in the lab, as well as developing and maintaining non-proprietary assays. Previous to that, he was also the Bioanalytical Director at WIL Research and the Director of Bioanalytical Services at Pyxant Labs.”